Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 21, 2019 Off

Catabasis Pharmaceuticals Presents Preclinical Data Showing Potential for Bone Preservation with Edasalonexent in Duchenne Muscular Dystrophy

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today presented new preclinical data showing preserved bone health with…

June 21, 2019 Off

Global Oral Biologics Market to Surpass US$ 8,087.5 Million by 2026 – Coherent Market Insights

By BusinessWire

SEATTLE–(BUSINESS WIRE)–#GlucagonlikePeptide1ReceptorAgonist–According to Coherent Market Insights, the global oral biologics market was valued at US$ 834.3 million in 2018, and…

June 21, 2019 Off

California Life Sciences Association (CLSA) Announces Partnership with Brex to Bring Savings to Members

By BusinessWire

Life sciences credit card provides exclusive savings to CLSA members, including 60,000 bonus points, tailored rewards, dedicated support, and more…

June 21, 2019 Off

Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2019

By BusinessWire

HAWTHORNE, N.Y.–(BUSINESS WIRE)–Taro Pharmaceutical Industries Ltd. (NYSE: TARO, “Taro”) announced that its Annual Report on Form 20-F for the fiscal…

June 21, 2019 Off

Global Custom Recombinant Protein Production Services Market to Surpass US$ 6.7 Billion by 2026

By BusinessWire

SEATTLE–(BUSINESS WIRE)–#CustomRecombinantProtein–According to Coherent Market Insights, the global custom recombinant protein production services market was valued at US$ 2,600.21 million…

June 21, 2019 Off

Protein Stability Analysis Market, 2024 by Product (Assay & Reagent, Instrument), Technique (Chromatography, Spectroscopy, SPR, DSF), End User (Pharmaceutical & Biotech Companies, Research Institute) – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Protein Stability Analysis Market by Product (Assay & Reagent, Instrument), Technique (Chromatography, Spectroscopy, SPR, DSF), End User (Pharmaceutical…

June 21, 2019 Off

ImmunSYS, Inc. Adds New Members to Its Board of Directors

By BusinessWire

FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–#immunotherapy–ImmunSYS, Inc., a clinical stage biotechnology company focused on the development of innovative cancer immunotherapy products, announced…

June 21, 2019 Off

ImmunSYS, Inc. Adds New Members to Its Board of Directors

By BusinessWire

FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–#immunotherapy–ImmunSYS, Inc., a clinical stage biotechnology company focused on the development of innovative cancer immunotherapy products, announced…

June 21, 2019 Off

Ocular Therapeutix™ Announces FDA Approval of Supplemental New Drug Application (sNDA) for DEXTENZA® (0.4 Dexamethasone Intracanalicular Insert for Ophthalmic Use) for the Treatment of Ocular Inflammation Following Ophthalmic Surgery

By BusinessWire

DEXTENZA® Now Approved for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery BEDFORD, Mass.–(BUSINESS WIRE)–$OCUL #OCUTX–Ocular Therapeutix™, Inc.…

June 21, 2019 Off

Ocular Therapeutix™ Announces FDA Approval of Supplemental New Drug Application (sNDA) for DEXTENZA® (0.4 Dexamethasone Intracanalicular Insert for Ophthalmic Use) for the Treatment of Ocular Inflammation Following Ophthalmic Surgery

By BusinessWire

DEXTENZA® Now Approved for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery BEDFORD, Mass.–(BUSINESS WIRE)–$OCUL #OCUTX–Ocular Therapeutix™, Inc.…

Posts pagination

Previous 1 … 3,056 3,057 3,058 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine